‘Jurassic World: Rebirth' brings fans back to dangerous dinosaur realm
Actors Jonathan Bailey, Scarlett Johansson, Rupert Friend and Mahershala Ali attend the "Jurassic World Rebirth" global premiere in London, Britain, June 17, 2025. REUTERS/Carlos Jasso
LONDON (Reuters) -Scarlett Johansson's role in "Jurassic World: Rebirth" made her recall her earliest memories of the dinosaur film franchise.
The "Black Widow" actor recalled seeing the first "Jurassic Park" film at the movie theater when she was 10 years old.
'It imprinted on me very deeply,' she told Reuters at the London premiere at Odeon Luxe Leicester Square.
'For the next three decades, I was like, I would have done anything to be in a Jurassic movie in any capacity,' she added.
The franchise, created by Michael Crichton, has spawned several films, merchandising deals and video games.
"Jurassic World: Rebirth," directed by Gareth Edwards, follows a team of specialists that embarks on an expedition to a forbidden island, home to a research facility for the original 'Jurassic Park'.
The specialists, played by Johansson and "Bridgerton" actor Jonathan Bailey, must obtain DNA samples from three dinosaurs to achieve a life-saving medical breakthrough.
The Universal Pictures film arrives in theaters on July 2.
For Rupert Friend, this installment in the franchise is exhilarating.
'I love adventure. I love being taken on a ride where you don't know what's going to happen. I love the unknown. I love risk,' he said.
For well-known science fiction director, Edwards, the pressure for the film to succeed did not hit until he arrived at the premiere.
'It's all front and centre here. It feels a bit weird to be honest. I can't quite get my head around it,' the "Rogue One: A Star Wars Story" director added.
(Reporting by Francesca Halliwell and Danielle Broadway; Editing by David Gregorio)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
18 minutes ago
- The Star
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
FILE PHOTO: A NVIDIA logo is shown at SIGGRAPH 2017 in Los Angeles, California, U.S. July 31, 2017. REUTERS/Mike Blake SAN FRANCISCO (Reuters) -SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a trove of data it hopes will speed up the discovery of new medical treatments by helping scientists understand how drugs stick to proteins. The goal is to help scientists predict whether a drug will bind to its target in the human body. But while the data is backed up by real-world scientific experiments, it did not come from a lab. Instead, SandboxAQ, which has raised nearly $1 billion in venture capital, generated the data using Nvidia's chips and will feed it back into AI models that it hopes scientists can use to rapidly predict whether a small-molecule pharmaceutical will bind to the protein that researchers are targeting, a key question that must be answered before a drug candidate can move forward. For example, if a drug is meant to inhibit a biological process like the progression of a disease, scientists can use the tool to predict whether the drug molecule is likely to bind to the proteins involved in that process. The approach is an emerging field that combines traditional scientific computing techniques with advancements in AI. In many fields, scientists have long had equations that can precisely predict how atoms combine into molecules. But even for relatively small three-dimensional pharmaceutical molecules, the potential combinations become far too vast to calculate manually, even with today's fastest computers. So SandboxAQ's approach was to use existing experimental data to calculate about 5.2 million new, "synthetic" three-dimensional molecules - molecules that haven't been observed in the real world, but were calculated with equations based on real-world data. That synthetic data, which SandboxAQ is releasing publicly, can be used to train AI models that can predict whether a new drug molecule is likely to stick to the protein researchers are targeting in a fraction of the time it would take to calculate it manually, while retaining accuracy. SandboxAQ will charge money for its own AI models developed with the data, which it hopes will get results that rival running lab experiments, but virtually. "This is a long-standing problem in biology that we've all, as an industry, been trying to solve for," Nadia Harhen, general manager of AI simulation at SandboxAQ, told Reuters on Tuesday. "All of these computationally generated structures are tagged to a ground-truth experimental data, and so when you pick this data set and you train models, you can actually use the synthetic data in a way that's never been done before." (Reporting by Stephen Nellis; Editing by Leslie Adler)
The Star
13 hours ago
- The Star
Latin American countries to launch own AI model in September
FILE PHOTO: A message reading "AI artificial intelligence," a keyboard and robot hands are seen in this illustration created on January 27, 2025. REUTERS/Dado Ruvic/Illustration/File Photo SANTIAGO (Reuters) -A dozen Latin American countries are collaborating to launch Latam-GPT in September, the first large artificial intelligence language model trained to understand the region's diverse cultures and linguistic nuances, Chilean officials said on Tuesday. This open-source project, steered by Chile's state-run National Center for Artificial Intelligence (CENIA) alongside over 30 regional institutions, seeks tosignificantly increase the uptake and accessibility of AI across Latin America. Chilean Science Minister Aisen Etcheverry said the project "could be a democratizing element for AI," envisioning its application in schools and hospitals with a model that reflects the local culture and language. Developed starting in January 2023, Latam-GPT seeks to overcome inaccuracies and performance limitations of global AI models predominantly trained on English. Officials said that it was meant to be the core technology for developing applications like chatbots, not a direct competitor to consumer products like ChatGPT. A key goal is preserving Indigenous languages, with an initial translator already developed forRapa Nui, Easter Island's native language. The project plans to extend this to other Indigenous languages for applications like virtual public service assistants and personalized education systems. The model is based on Llama 3 AI technology and is trained using a regional network of computers, including facilities at Chile's University of Tarapaca and cloud-based systems. Regional development bank CAF and Amazon Web Services have supported it. While currently lacking a dedicated budget, CENIA head Alvaro Soto hopes that demonstrating the system's capabilities will attract more funding. (Reporting by Fabian Cambero; Editing by Lisa Shumaker)
The Star
15 hours ago
- The Star
‘Jurassic World: Rebirth' brings fans back to dangerous dinosaur realm
Actors Jonathan Bailey, Scarlett Johansson, Rupert Friend and Mahershala Ali attend the "Jurassic World Rebirth" global premiere in London, Britain, June 17, 2025. REUTERS/Carlos Jasso LONDON (Reuters) -Scarlett Johansson's role in "Jurassic World: Rebirth" made her recall her earliest memories of the dinosaur film franchise. The "Black Widow" actor recalled seeing the first "Jurassic Park" film at the movie theater when she was 10 years old. 'It imprinted on me very deeply,' she told Reuters at the London premiere at Odeon Luxe Leicester Square. 'For the next three decades, I was like, I would have done anything to be in a Jurassic movie in any capacity,' she added. The franchise, created by Michael Crichton, has spawned several films, merchandising deals and video games. "Jurassic World: Rebirth," directed by Gareth Edwards, follows a team of specialists that embarks on an expedition to a forbidden island, home to a research facility for the original 'Jurassic Park'. The specialists, played by Johansson and "Bridgerton" actor Jonathan Bailey, must obtain DNA samples from three dinosaurs to achieve a life-saving medical breakthrough. The Universal Pictures film arrives in theaters on July 2. For Rupert Friend, this installment in the franchise is exhilarating. 'I love adventure. I love being taken on a ride where you don't know what's going to happen. I love the unknown. I love risk,' he said. For well-known science fiction director, Edwards, the pressure for the film to succeed did not hit until he arrived at the premiere. 'It's all front and centre here. It feels a bit weird to be honest. I can't quite get my head around it,' the "Rogue One: A Star Wars Story" director added. (Reporting by Francesca Halliwell and Danielle Broadway; Editing by David Gregorio)
